About the alliance
Unifying support for a fragmented but urgent field.
Congenital heart disease is the most common birth defect in the world. Yet the industry building its future needs practical support. The Global Congenital Heart Alliance is being built to change that.
The gap
The heroes of CHD need support
Too many innovators in congenital heart disease face the journey alone—navigating complex regulatory pathways, overcoming limited market incentives, securing funding, building clinical partnerships, and bringing life-changing technologies to patients. Our organization exists to provide the guidance, connections, expertise, and collaborative ecosystem needed to bridge these gaps. By supporting clinicians, researchers, entrepreneurs, and industry partners at every stage of development, we help transform promising ideas into accessible solutions that improve the lives of children and adults living with congenital heart disease.
Mission
To accelerate the development, commercialization, accessibility, and global adoption of congenital cardiovascular technologies through collaboration, advocacy, innovation, and industry leadership.
Vision
The leading global support ecosystem for congenital cardiovascular innovation — connecting industry, clinicians, researchers, regulators, investors, and patient communities to improve outcomes worldwide.
The model
A hybrid industry association and innovation consortium.
Industry association
Membership, advocacy, policy engagement, educational programming.
Innovation consortium
Multi-center collaboration, shared research, startup acceleration, commercial matchmaking.
Convening platform
Regular summits, innovation showcases, investor forums, regulatory roundtables.